Maravai LifeSciences Holdings's total inventories for the quarter that ended in Mar. 2026 was MXN730 Mil. Maravai LifeSciences Holdings's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was MXN729 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Maravai LifeSciences Holdings's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was MXN-35.51.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Maravai LifeSciences Holdings's Days Inventory for the
three
months ended in Mar. 2026 was 114.85.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Maravai LifeSciences Holdings's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Maravai LifeSciences Holdings's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.61.
Maravai LifeSciences Holdings (MEX:MRVI) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Maravai LifeSciences Holdings's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Maravai LifeSciences Holdings's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Maravai LifeSciences Holdings Total Inventories Related Terms
Maravai LifeSciences Holdings Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings Total Inventories Chart
Maravai LifeSciences Holdings Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Maravai LifeSciences Holdings (MEX:MRVI) has a Total Inventories of MXN730 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Maravai LifeSciences Holdings and its competitors.
Is Maravai LifeSciences Holdings' Total Inventories too high?
Maravai LifeSciences Holdings' current Total Inventories is MXN730 Mil. Overall, Maravai LifeSciences Holdings has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Total Inventories compare to ANRO and BBOT?
Maravai LifeSciences Holdings' Total Inventories of MXN730 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Biotechnology company?
A good Total Inventories depends on the Biotechnology industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Maravai LifeSciences Holdings and its competitors. Maravai LifeSciences Holdings's current Total Inventories is MXN730 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current Total Inventories of MXN730 Mil. The stock's GF Value™ is MXN53.06, compared to a current price of MXN85.00 — trading 60.2% above its estimated fair value. The current Total Inventories is MXN730 Mil. Maravai LifeSciences Holdings' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current Total Inventories is MXN730 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?
Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued.
The current stock price of MXN85.00 is trading 60.2% above its estimated GF Value™ of MXN53.06.
Key valuation signals for MEX:MRVI:
Total Inventories: MXN730 Mil
GF Value™: MXN53.06 vs. price of MXN85.00 (60.2% above fair value)
No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maravai LifeSciences Holdings Business Description
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
62GF Score
Get the complete analysis for MEX:MRVI
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MRVI has been successfully added to your 
